Swiss National Bank’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15M Buy
232,700
+2,000
+0.9% +$141K 0.01% 760
2025
Q4
$15.5M Sell
230,700
-8,200
-3% -$552K 0.01% 758
2025
Q3
$17.5M Buy
238,900
+2,900
+1% +$193K 0.01% 691
2025
Q2
$12.3M Sell
236,000
-10,500
-4% -$597K 0.01% 820
2025
Q1
$15.7M Sell
246,500
-2,100
-0.8% -$122K 0.01% 689
2024
Q4
$11.9M Hold
248,600
0.01% 850
2024
Q3
$14.2M Sell
248,600
-1,300
-0.5% -$74.5K 0.01% 763
2024
Q2
$13.1M Sell
249,900
-11,000
-4% -$482K 0.01% 767
2024
Q1
$10.6M Buy
260,900
+900
+0.3% +$33.7K 0.01% 888
2023
Q4
$9.61M Sell
260,000
-29,400
-10% -$1.11M 0.01% 909
2023
Q3
$11.1M Sell
289,400
-5,400
-2% -$221K 0.01% 833
2023
Q2
$10.6M Buy
294,800
+3,000
+1% +$102K 0.01% 874
2023
Q1
$11.1M Sell
291,800
-40,800
-12% -$1.91M 0.01% 826
2022
Q4
$18.9M Buy
332,600
+5,500
+2% +$282K 0.01% 648
2022
Q3
$12.9M Buy
327,100
+2,700
+0.8% +$119K 0.01% 762
2022
Q2
$14.3M Buy
324,400
+8,200
+3% +$355K 0.01% 742
2022
Q1
$12.6M Buy
316,200
+18,600
+6% +$663K 0.01% 875
2021
Q4
$12M Sell
297,600
-1,300
-0.4% -$48.5K 0.01% 911
2021
Q3
$12.2M Buy
298,900
+15,600
+6% +$652K 0.01% 897
2021
Q2
$12.9M Sell
283,300
-10,100
-3% -$447K 0.01% 891
2021
Q1
$12.2M Sell
293,400
-900
-0.3% -$41.1K 0.01% 882
2020
Q4
$12.6M Buy
294,300
+1,100
+0.4% +$39.5K 0.01% 816
2020
Q3
$7.71M Hold
293,200
0.01% 934
2020
Q2
$7.86M Buy
293,200
+37,500
+15% +$846K 0.01% 896
2020
Q1
$4.6M Buy
255,700
+3,700
+1% +$70.2K ﹤0.01% 975
2019
Q4
$4.47M Buy
252,000
+5,500
+2% +$95.3K ﹤0.01% 1232
2019
Q3
$3.82M Buy
246,500
+3,600
+1% +$59.3K ﹤0.01% 1261
2019
Q2
$4.17M Buy
242,900
+5,800
+2% +$93.6K ﹤0.01% 1233
2019
Q1
$3.82M Buy
237,100
+7,500
+3% +$122K ﹤0.01% 1256
2018
Q4
$3.36M Buy
229,600
+3,600
+2% +$57.4K ﹤0.01% 1226
2018
Q3
$4.11M Buy
226,000
+3,500
+2% +$61.3K ﹤0.01% 1242
2018
Q2
$3.75M Hold
222,500
﹤0.01% 1283
2018
Q1
$4.36M Buy
222,500
+4,900
+2% +$94.9K 0.01% 1126
2017
Q4
$4.41M Buy
217,600
+11,100
+5% +$204K ﹤0.01% 1136
2017
Q3
$3.59M Hold
206,500
﹤0.01% 1238
2017
Q2
$2.65M Buy
206,500
+26,000
+14% +$347K ﹤0.01% 1400
2017
Q1
$2.34M Hold
180,500
﹤0.01% 1469
2016
Q4
$1.78M Hold
180,500
﹤0.01% 1629
2016
Q3
$2.18M Sell
180,500
-4,500
-2% -$46K ﹤0.01% 1447
2016
Q2
$1.6M Hold
185,000
﹤0.01% 1663
2016
Q1
$1.69M Buy
185,000
+36,200
+24% +$341K ﹤0.01% 1545
2015
Q4
$2.58M Hold
148,800
0.01% 1161
2015
Q3
$2M Buy
148,800
+18,500
+14% +$371K 0.01% 1310
2015
Q2
$2.94M Buy
130,300
+12,700
+11% +$223K 0.01% 1076
2015
Q1
$1.68M Hold
117,600
﹤0.01% 1410
2014
Q4
$1.14M Buy
117,600
+2,600
+2% +$23.1K ﹤0.01% 1661
2014
Q3
$1.05M Hold
115,000
﹤0.01% 1640
2014
Q2
$1.14M Hold
115,000
﹤0.01% 1641
2014
Q1
$1.46M Buy
115,000
+33,900
+42% +$503K 0.01% 1444
2013
Q4
$1.22M Hold
81,100
﹤0.01% 1379
2013
Q3
$895K Buy
81,100
+8,300
+11% +$69.2K ﹤0.01% 1531
2013
Q2
$578K Buy
+72,800
New +$464K ﹤0.01% 1807

Other funds holding HALO

Swiss National Bank's HALO Position: Q1 2026 in Review

Swiss National Bank increased its Halozyme (HALO) stake by 0.87% in Q1 2026, buying an estimated $141K and bringing the position to 232,700 shares worth $15M. The position accounts for 0.01% of the portfolio, ranked #760.

Swiss National Bank first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.9M in Q4 2022. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Swiss National Bank held 232,700 shares of Halozyme worth $15M as of Q1 2026.
  • Swiss National Bank bought 2,000 Halozyme shares in Q1 2026, an estimated $141K.
  • Halozyme made up 0.01% of Swiss National Bank's portfolio in Q1 2026, its #760 holding.
  • Swiss National Bank first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • Swiss National Bank's Halozyme position peaked at $18.9M in Q4 2022.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.